AG
EXEL icon

Aperio Group’s Exelixis EXEL Stock Holding History

Aperio Group’s Portfolio EXEL Stock Details EXEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$1.19M Sell
59,100
-10,448
-15% -$219K ﹤0.01% 1497
2020
Q3 		$1.7M Buy
69,548
+2,021
+3% +$47.2K 0.01% 1194
2020
Q2 		$1.6M Buy
67,527
+10,013
+17% +$232K 0.01% 1206
2020
Q1 		$990K Sell
57,514
-611
-1% -$11.2K ﹤0.01% 1314
2019
Q4 		$1.02M Sell
58,125
-24,374
-30% -$413K ﹤0.01% 1423
2019
Q3 		$1.46M Sell
82,499
-3,896
-5% -$78.9K 0.01% 1203
2019
Q2 		$1.85M Buy
86,395
+9,835
+13% +$206K 0.01% 1101
2019
Q1 		$1.82M Buy
76,560
+9,642
+14% +$220K 0.01% 1072
2018
Q4 		$1.32M Buy
66,918
+18,072
+37% +$322K 0.01% 1167
2018
Q3 		$865K Sell
48,846
-2,652
-5% -$51.7K ﹤0.01% 1485
2018
Q2 		$1.11M Sell
51,498
-3,531
-6% -$73K 0.01% 1321
2018
Q1 		$1.22M Sell
55,029
-5,577
-9% -$154K 0.01% 1220
2017
Q4 		$1.84M Sell
60,606
-2,951
-5% -$78.5K 0.01% 1011
2017
Q3 		$1.54M Buy
63,557
+5,212
+9% +$139K 0.01% 1048
2017
Q2 		$1.44M Buy
58,345
+1,514
+3% +$32K 0.01% 1057
2017
Q1 		$1.23M Sell
56,831
-12,668
-18% -$258K 0.01% 1074
2016
Q4 		$1.04M Sell
69,499
-7,672
-10% -$111K 0.01% 1112
2016
Q3 		$987K Sell
77,171
-15,114
-16% -$163K 0.01% 1104
2016
Q2 		$721K Buy
92,285
+4,770
+5% +$27.5K 0.01% 1217
2016
Q1 		$350K Buy
87,515
+3,410
+4% +$14.4K ﹤0.01% 1566
2015
Q4 		$474K Buy
84,105
+8,631
+11% +$48.3K ﹤0.01% 1363
2015
Q3 		$423K Buy
75,474
+4,415
+6% +$24K ﹤0.01% 1393
2015
Q2 		$267K Sell
71,059
-173
-0.2% -$562 ﹤0.01% 1704
2015
Q1 		$183K Sell
71,232
-56,572
-44% -$131K ﹤0.01% 1848
2014
Q4 		$184K Buy
127,804
+98,296
+333% +$153K ﹤0.01% 1764
2014
Q3 		$45K Buy
+29,508
New +$94.7K ﹤0.01% 1720

Other funds holding EXEL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
MG
Meditor Group Hamilton, Bermuda $48.1M AUM 38.67% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return

Aperio Group's EXEL Position: Q4 2020 in Review

Aperio Group reduced its Exelixis (EXEL) stake by 15% in Q4 2020, selling an estimated $219K and leaving 59,100 shares worth $1.19M. The position accounts for ﹤0.01% of the portfolio, ranked #1497.

Aperio Group first reported a position in EXEL in Q3 2014 and has held it in 26 quarters since. The position peaked at $1.85M in Q2 2019. 352 funds tracked by Wall St. Rank hold EXEL as of Q4 2020.

  • Aperio Group held 59,100 shares of Exelixis worth $1.19M as of Q4 2020.
  • Aperio Group sold 10,448 Exelixis shares in Q4 2020, an estimated $219K.
  • Exelixis made up ﹤0.01% of Aperio Group's portfolio in Q4 2020, its #1497 holding.
  • Aperio Group first reported a position in Exelixis in Q3 2014 and has held it in 26 quarters since.
  • Aperio Group's Exelixis position peaked at $1.85M in Q2 2019.
  • 352 funds tracked by Wall St. Rank held Exelixis as of Q4 2020.

Based on Aperio Group's 13F filing for Q4 2020, filed 5 Feb 2021.